Breaking News, Promotions & Moves

Regenxbio Appoints Chief Financial Officer

Mitchell Chan succeeds Vit Vasista as EVP and CFO, effective today.

Author Image

By: Charlie Sternberg

Associate Editor

Regenxbio Inc. has appointed Mitchell Chan as Executive Vice President and Chief Financial Officer, effective today.   A veteran finance executive and operating partner in the biotechnology industry, Chan has held key roles in raising capital, business development transactions and operations for nearly 20 years.    He succeeds Vit Vasista, who served as Executive Vice President and Chief Financial Officer since 2009. Vasista will serve as an advisor to the Company through January 3, 2025, to...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters